# Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

> **NCT05306873** · PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 12 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Placebo for Mycophenolate Mofetil
- **DRUG:** Voclosporin
- **DRUG:** Placebo for Voclosporin
- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT05306873
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-11-30
- **Primary completion:** 2024-06-13
- **Final completion:** 2024-07-11
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** The study was closed due to slow enrollment.
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05306873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05306873, "Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT05306873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*